How do you build a high-value life science tools company that investors want to back—and acquirers need to buy? Dr. Mike Stadnisky, former CEO of Phitonex (acquired by Thermo Fisher) and FlowJo (acquired by BD), shares battle-tested strategies for...

✅ Pitch decks that work – Why TAM/SAM/SOM slides are irrelevant (and what to replace them with)
✅ Investor psychology – How to structure your cap table for alignment (and avoid dilution traps)
✅ Commercialization hacks – Why "get on a plane" beats another Zoom call for critical deals
✅ The Thielsen Capital filter – What makes his syndicate write checks (and what gets 600+ startups rejected)

If you're raising for a tools, diagnostics, or research tech startup, this is your playbook for moving from science project to scalable business—without wasting years (or equity) on the wrong path.